A detailed history of Samsara Bio Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 6,788,609 shares of SRRK stock, worth $280 Million. This represents 31.52% of its overall portfolio holdings.

Number of Shares
6,788,609
Previous 6,788,609 -0.0%
Holding current value
$280 Million
Previous $56.5 Million 3.84%
% of portfolio
31.52%
Previous 29.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $14.3 Million - $44.5 Million
2,189,781 Added 47.62%
6,788,609 $128 Million
Q1 2023

May 15, 2023

BUY
$7.36 - $12.72 $33.8 Million - $58.5 Million
4,598,828 New
4,598,828 $36.8 Million
Q2 2022

Aug 15, 2022

BUY
$4.66 - $13.96 $19.8 Million - $59.5 Million
4,259,217 Added 1254.15%
4,598,828 $25.2 Million
Q1 2022

May 16, 2022

BUY
$11.89 - $24.68 $4.04 Million - $8.38 Million
339,611 New
339,611 $4.38 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.13B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.